These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3686005)

  • 21. More about cancer incidence in atomic bomb survivors: solid tumors, 1958-1987.
    Ron E; Preston DL; Mabuchi K
    Radiat Res; 1995 Jan; 141(1):126-7. PubMed ID: 7997509
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radiation risks. Results of the new evaluation].
    Kellerer AM
    Radiologe; 1991 May; 31(5):227-34. PubMed ID: 1876693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Survey of the newest reports on late damages caused by the atomic bomb explosions in Hiroshima and Nagasaki (1965)].
    Akimoto S; Kusano N; Nakamura H; Shiga H
    Dtsch Gesundheitsw; 1966 Jun; 21(26):1206-11. PubMed ID: 5955616
    [No Abstract]   [Full Text] [Related]  

  • 24. Comment on the contribution of neutrons to the biological effect at Hiroshima.
    Rossi HH; Zaider M
    Radiat Res; 1996 Nov; 146(5):590-3. PubMed ID: 8896588
    [No Abstract]   [Full Text] [Related]  

  • 25. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of atomic bomb survivors. Understanding radiation effects.
    Boice JD
    JAMA; 1990 Aug; 264(5):622-3. PubMed ID: 2366304
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.
    Schneider U; Walsh L
    Radiat Environ Biophys; 2008 Apr; 47(2):253-63. PubMed ID: 18157543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M
    J Radiat Res; 1979 Dec; 20(4):307-21. PubMed ID: 536952
    [No Abstract]   [Full Text] [Related]  

  • 29. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid tumors in atomic bomb survivors in Hiroshima: a review.
    Takeichi N; Dohi K; Ito H; Yamamoto H; Mabuchi K; Yamamoto T; Shimaoka K; Yokoro K
    J Radiat Res; 1991 Mar; 32 Suppl():189-92. PubMed ID: 1762105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New dosimetry of atomic bomb radiations.
    Fry RJ; Sinclair WK
    Lancet; 1987 Oct; 2(8563):845-8. PubMed ID: 2889042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation cancers and A-bomb survivors.
    Stewart A
    Lancet; 1971 Nov; 2(7735):1203. PubMed ID: 4108008
    [No Abstract]   [Full Text] [Related]  

  • 33. Delayed radiation effects in atomic-bomb survivors. Major observations by the Atomic Bomb Casualty Commission are evaluated.
    Miller RW
    Science; 1969 Oct; 166(3905):569-74. PubMed ID: 4898614
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 35. Childhood cancer in relation to prenatal exposure to atomic-bomb radiation.
    Jablon S; Kato H
    Lancet; 1970 Nov; 2(7681):1000-3. PubMed ID: 4098041
    [No Abstract]   [Full Text] [Related]  

  • 36. Dose-response analyses for the Japanese A-bomb survivors.
    Muirhead CR; Butland BK
    Health Phys; 1989 Dec; 57(6):1035-6. PubMed ID: 2584020
    [No Abstract]   [Full Text] [Related]  

  • 37. Supra-linear dose-response in the A-bomb study.
    Gofman JW
    Health Phys; 1989 Dec; 57(6):1037-8. PubMed ID: 2584021
    [No Abstract]   [Full Text] [Related]  

  • 38. Late physical disturbances caused by atomic bomb explosions in Japan.
    Kusano N; Shiga H
    Scand J Soc Med Suppl; 1982; 31():60-3. PubMed ID: 6764030
    [No Abstract]   [Full Text] [Related]  

  • 39. RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS DERIVED FROM THE EXCESS RELATIVE RISK MODEL WITH THE ATOMIC BOMB SURVIVORS DATA MANAGED BY HIROSHIMA UNIVERSITY.
    Satoh K; Yasuda H; Kawakami H; Tashiro S
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):346-350. PubMed ID: 29036656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Thyroid cancer: reports up to date and a review.
    Takeichi N; Ezaki H; Dohi K
    J Radiat Res; 1991 Mar; 32 Suppl():180-8. PubMed ID: 1762104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.